Tilray Brands (TLRY) Operating Income (2017 - 2026)
Tilray Brands' (TLRY) quarterly Operating Income came in at -$16.5 million in Q2 2026, up 98.86% YoY from -$8.3 million in Q2 2025, and up 37.64% on a QoQ basis from -$26.4 million in Q1 2026.
Tilray Brands (TLRY) Operating Income (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Operating Income data on file, last reported at -$16.5 million in Q2 2026.
- Quarterly Operating Income rose 98.86% year-over-year to -$16.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$63.0 million (up 97.24% YoY) and the FY2026 annual result came in at -$63.0 million, up 97.24% from the prior year.
- Operating Income climbed to -$16.5 million in Q2 2026, from -$26.4 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $2.1 million in Q3 2025 to a low of -$1.4 billion in Q2 2025.
- A 5-year average of -$243.1 million and a median of -$39.2 million in 2023 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 105.72% in 2025, down 8637.66% in 2025.
- Tracing TLRY's Operating Income over 5 years: stood at -$51.8 million in 2022, then grew by 19.37% to -$41.8 million in 2023, then decreased by 1.1% to -$42.2 million in 2024, then soared by 47.23% to -$22.3 million in 2025, then gained by 26.15% to -$16.5 million in 2026.
- The last three Operating Income figures came in at -$16.5 million (Q2 2026), -$26.4 million (Q1 2026), and -$22.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Tilray Brands | 516.53 Mn | 281.90 Mn | 90.52 Mn | -16.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -16.45 Mn |
| Feb 28, 2026 | -26.39 Mn |
| Nov 30, 2025 | -22.28 Mn |
| Aug 31, 2025 | 2.09 Mn |
| May 31, 2025 | -1.44 Bn |
| Feb 28, 2025 | -759.93 Mn |
| Nov 30, 2024 | -42.22 Mn |
| Aug 31, 2024 | -36.57 Mn |
| May 31, 2024 | -16.53 Mn |
| Feb 29, 2024 | -82.10 Mn |
| Nov 30, 2023 | -41.76 Mn |
| Aug 31, 2023 | -34.36 Mn |
| May 31, 2023 | -89.98 Mn |
| Feb 28, 2023 | -1.21 Bn |
| Nov 30, 2022 | -51.79 Mn |
| Aug 31, 2022 | -21.18 Mn |
| May 31, 2022 | -467.42 Mn |
| Feb 28, 2022 | -18.08 Mn |
| Nov 30, 2021 | -55.53 Mn |
| Aug 31, 2021 | -69.37 Mn |